Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial
白细胞介素 6 单克隆抗体治疗系统性红斑狼疮的疗效和安全性:一项 II 期剂量范围随机对照试验
期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2016-209668
Wallace, Daniel J; Strand, Vibeke; Merrill, Joan T; Popa, Serghei; Spindler, Alberto J; Eimon, Alicia; Petri, Michelle; Smolen, Josef S; Wajdula, Joseph; Christensen, Jared; Li, Cheryl; Diehl, Annette; Vincent, Michael S; Beebe, Jean; Healey, Paul; Sridharan, Sudhakar